NephroGenex To Present At BioEquity Europe 2014 Conference
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Pierre Legault, Chief Executive Officer, will present a corporate overview at the 15th annual BioEquity Europe conference at the Hilton Amsterdam Hotel in Amsterdam.
Help employers find you! Check out all the jobs and post your resume.